Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
208.50
+18.50 (9.74%)
At close: Sep 12, 2025
157.41%
Market Cap 13.89B
Revenue (ttm) 1.63B
Net Income (ttm) 246.95M
Shares Out 60.00M
EPS (ttm) 4.11
PE Ratio 56.33
Forward PE n/a
Dividend 4.03 (1.83%)
Ex-Dividend Date Aug 25, 2025
Volume 2,070,638
Average Volume 1,063,864
Open 190.00
Previous Close 190.00
Day's Range 190.00 - 208.50
52-Week Range 81.00 - 401.00
Beta n/a
RSI 40.44
Earnings Date Nov 12, 2025

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. is a subsidiary of Sunfun Info Co., Ltd. [Read more]

Industry Pharmaceutical Preparations
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 7780
Full Company Profile

Financial Performance

In 2024, Daiken Biomedical's revenue was 1.36 billion, an increase of 14.45% compared to the previous year's 1.19 billion. Earnings were 106.58 million, a decrease of -33.54%.

Financial Statements

News

There is no news available yet.